OsteopetrosisPathogenesis and Rationale for the Use of Interferon-γ-1b
被引:0
|
作者:
Lakshmi Shankar
论文数: 0引用数: 0
h-index: 0
机构:Medical University of South Carolina,Department of Pediatrics and General Clinical Research Center
Lakshmi Shankar
Egbert J. A. Gerritsen
论文数: 0引用数: 0
h-index: 0
机构:Medical University of South Carolina,Department of Pediatrics and General Clinical Research Center
Egbert J. A. Gerritsen
L. Lyndon Key
论文数: 0引用数: 0
h-index: 0
机构:Medical University of South Carolina,Department of Pediatrics and General Clinical Research Center
L. Lyndon Key
机构:
[1] Medical University of South Carolina,Department of Pediatrics and General Clinical Research Center
[2] Hospital for Sick Children NHS Trust and Institute of Child Health,Department of Immunology
来源:
BioDrugs
|
1997年
/
7卷
关键词:
Bone Resorption;
Chronic Granulomatous Disease;
Osteopetrosis;
Osteoclastic Bone Resorption;
Dietary Calcium Intake;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Congenital osteopetrosis is a group of disorders resulting in decreased osteoclastic function and hence decreased bone resorption. Various medical treatments have been attempted to ameliorate the osteopetrotic condition. A calcium-deficient diet has limited further sclerosis in some patients. Prednisone therapy has improved haematological function in some patients, but has not resulted in a reduction in bone mass. Calcitrophic hormones, such as parathyroid hormone (PTH) infusions and oral calcitriol, stimulate osteoclastic activity, and calcitriol in particular has stimulated osteoclastic bone resorption in some patients with osteopetrosis. Bone marrow transplantation, although curative, is limited by paucity of donors, risk of graft-versus-host disease and relapse of the disease.